Avrion Mitchison Prize
Avrion Mitchison Preis
In honor of its founding director Avrion Mitchison, the DRFZ annually awards the Avrion Mitchison Prize to young scientists. The award recognizes publications or dissertations that make a significant contribution to the understanding and treatment of rheumatic diseases.
The Avrion Mitchison Prize is endowed with 3,000 euros. Since 2019, the prize has been sponsored by the DRFZ, previously it was funded by the Ernst Schering Foundation from 1999 to 2018.
The award ceremony will take place in the fall as part of an event to mark World Rheumatism Day.
Über Avrion Mitchison
Avrion (Av) Mitchison (1928 – 2022) was a British biologist and immunologist. With his work on immunological tolerance, immune regulation and the cooperation of T and B lymphocytes, he has made a significant contribution to our understanding of the immune system.
From 1991 to 1996, he was the first Scientific Director of the then newly founded DRFZ. He established the research field of immunology of rheumatic diseases, in which various research groups investigate the cells and mechanisms that underlie the development and maintenance of rheumatic diseases.
Avrion Mitchison’s research has not only paved the way for research into autoimmune diseases. His findings also formed the basis for new, targeted therapeutic approaches aimed at restoring immunological self-tolerance and thus sustainably improving the treatment of rheumatic diseases.
Avrion Mitchison Preisträger
2024 und 2025 wurde der Avrion Mitchison Preis nicht ausgeschrieben
2023 Timo Rückert, Deutsches Rheuma-Forschungszentrum Berlin, ein Leibniz-Institut
Interview auf YouTube
Vortrag auf YouTube
2022 Maria Dzamukova, Deutsches Rheuma-Forschungszentrum Berlin, ein Leibniz-Institut
Vortrag auf YouTube
2021 Denise Beckmann, Institute of Musculoskelezal Medicine (IMM), University Hospital Münster
Interview auf YouTube
Vortrag auf YouTube
2020
Richard Addo, Medigene AG, München
Interview auf YouTube
Vortrag auf YouTube
Lennard Ostendorf, Charité – Universitätsmedizin Berlin und Deutsches Rheuma-Forschungszentrum Berlin
Interview auf YouTube
Vortrag auf YouTube
2019 Anika Grüneboom und Stephan Culemann, Friedrich-Alexander-Universität Erlangen-Nürnberg
2018 Quirin Hammer, Karolinska Institut, Stockholm, SE
2017 Rafael Leite Dantas, Universität Münster
2016 Corinna Wehmeyer, University of Brimingham, UK
2015 Christian Neumann und Caroline von Spee-Mayer, Charité – Universitätsmedizin Berlin und Deutsches Rheuma-Forschungszentrum Berlin
2014 Christine Schauer, Universität Erlangen-Nürnberg
2013 Dirk Baumjohann, University of California at San Francisco, US
2012 Stefan Uderhardt, Friedrich-Alexander-Universität Erlangen-Nürnberg
2011 Anna-Barbara Stittrich, Deutsches Rheuma-Forschungszentrum Berlin
2010 Edda Schulz, Institut Curie, Paris, FR
2009
Inka Albrecht, Deutsches Rheuma-Forschungszentrum Berlin
Kai Kessenbrock, University of California at San Francisco, US
2008 Kirsten Neubert, Universität Erlangen
2007 Thomas Tiller, Max-Planck-Institut für Infektionsbiologie, Berlin
2006 Varsha Kumar, Universität Bern, CH
2005 Ute Wellman, Friedrich-Alexander-Universität Erlangen-Nürnberg
2004
Bimba Franziska Hoyer, Charité – Universitätsmedizin Berlin und Deutsches Rheuma-Forschungszentrum Berlin
Bert Maier und David Schubert, Charité – Universitätsmedizin Berlin und Deutsches Rheuma-Forschungszentrum Berlin
2003 Anja E. Hauser, Deutsches Rheuma-Forschungszentrum Berlin
2002 Jochen Hühn und Joachim Lehmann
Charité – Universitätsmedizin Berlin und Deutsches Rheuma-Forschungszentrum Berlin
2001 Marcus Odendahl, Deutsches Rheuma-Forschungszentrum Berlin
2000
Max Löhning und Anne Richter, Deutsches Rheuma-Forschungszentrum Berlin
Verena Moos, Deutsches Rheuma-Forschungszentrum Berlin
1999 Carsten Bramlage, Thomas Häupl, Christian Kaps und Ute Ungethüm, Charité – Universitätsmedizin Berlin und Humboldt-Universität zu Berlin
Hasinger Lecture
The Albrecht Hasinger Lecture was jointly organized by the DRFZ and the Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin from 1994 to 2022. Every year, an internationally recognized scientific personality who has made a decisive contribution to the understanding and treatment of rheumatic diseases is invited to the DRFZ to give a lecture for the scientific community.
The Hasinger Lecture was held in honor of Albrecht Hasinger (1935-1994). As State Secretary in the Ministry of Health of the Berlin Senate at the time, he played a decisive role in the founding of the DRFZ in 1988. In doing so, he not only made an important contribution to Berlin as a center of science, but also provided impetus for the further development of the healthcare system – especially in rheumatology.
Albrecht Hasinger was the first President of the Board of Trustees of the DRFZ from 1989 to 1993.
Hasinger Lecturer
2022 Betty Diamond, Manhasset, NY, US
Innate immunity in neuroinflammation: the pivotal role of C1q?
Vortrag auf YouTube
2021 Pierre Miossec, Lyon, FR
IL-17 from discovery to targeting. How a protein without much interest became a key target in inflammation?
Vortrag auf YouTube
2020 Chris Buckley, Oxford, UK
The implications of the human cell atlas for targeting fibroblasts in immune mediated inflammatory diseases
Vortrag auf YouTube
2019 Desirée van der Heijde, Leiden, NL
Outcome assessment in rheumatology: a personal journey
2018 Richard K. Burt, Chicago, US
The future of HSCT for Multiple sclerosis and systemic sclerosis
2017 Stefan Rose-John, Kiel, DE
The biology of Interleukin-6 and its role in autoimmunity
2016 Mary B. Goldring, New York, US
The elusive search for a target in osteoarthritis therapy: Lessons from in vitro and in vivo models
2015 Michael Dustin, Oxford, UK
Mechanisms of information transfer at immunological synapses
2014 Frank Luyten, Lueven, BE
Reconstruction of the Joint: from Development to Engineering
2013 Tom WJ Huizinga, Leiden, NL
Immunological features of the development of RA over time
2012 Mark Shlomchik, New Haven, US
Lupus Pathogenesis: B vs. DC and other NET Results
2011 Peter E. Lipsky, Charlottesville, US
Development of new therapeutics for rheumatic diseases
2010 Paul-Peter Tak, Amsterdam, NL
Rheumatoid arthritis: from pathogenesis towards prevention of immune-mediated inflammatory disease
2009 Cornelia Weyand, Stanford, CA, US
The Immune System in Rheumatoid Arthritis – In Need for Rejuvenation
2008 Steffen Gay, Zürich, CH
Epigenetics in Rheumatoid Arthritis
2007 Joachim R. Kalden, Erlangen, DE
Aspects on the pathogenesis of systemic lupus erythematodes
2006 Maxime Dougados, Paris, FR
It’s good to feel better but it’s better to feel good: the current approach of the evaluation of musculoskeletal disorders
2005 Martin Weigert, Chicago, IL, US
The pros and cons of receptor editing
2004 Lars Klareskog, Stockholm, SE
2003 Diane Mathis, Boston, MA, US
2002 Bevra Hahn, Los Angeles, CA, US
2001 Iain McInnes, Glasgow, UK
2000 Ferdinand C. Breedveld, Leiden, NL
1999 Auli Toivanen, Paavo Toivanen, Turku, FI
1998 Nathan J. Zvaifler, San Diego, CA, US
1997 Derrick Brewerton, Westminster, UK
1996 Eng M. Tan, La Jolla, CA, US
1995 Frank A. Wollheim, Lund, SE
1994 Peter H. Schur, Boston, MA, US
